1. Home
  2. ZVRA vs TSAT Comparison

ZVRA vs TSAT Comparison

Compare ZVRA & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • TSAT
  • Stock Information
  • Founded
  • ZVRA 2006
  • TSAT 1969
  • Country
  • ZVRA United States
  • TSAT Canada
  • Employees
  • ZVRA N/A
  • TSAT N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • TSAT Metal Fabrications
  • Sector
  • ZVRA Health Care
  • TSAT Industrials
  • Exchange
  • ZVRA Nasdaq
  • TSAT Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • TSAT 394.3M
  • IPO Year
  • ZVRA 2015
  • TSAT 1996
  • Fundamental
  • Price
  • ZVRA $11.05
  • TSAT $23.43
  • Analyst Decision
  • ZVRA Strong Buy
  • TSAT
  • Analyst Count
  • ZVRA 9
  • TSAT 0
  • Target Price
  • ZVRA $23.25
  • TSAT N/A
  • AVG Volume (30 Days)
  • ZVRA 1.2M
  • TSAT 118.0K
  • Earning Date
  • ZVRA 08-12-2025
  • TSAT 08-06-2025
  • Dividend Yield
  • ZVRA N/A
  • TSAT N/A
  • EPS Growth
  • ZVRA N/A
  • TSAT N/A
  • EPS
  • ZVRA N/A
  • TSAT N/A
  • Revenue
  • ZVRA $40,588,000.00
  • TSAT $372,642,710.00
  • Revenue This Year
  • ZVRA $303.00
  • TSAT N/A
  • Revenue Next Year
  • ZVRA $77.66
  • TSAT N/A
  • P/E Ratio
  • ZVRA N/A
  • TSAT N/A
  • Revenue Growth
  • ZVRA 46.47
  • TSAT N/A
  • 52 Week Low
  • ZVRA $6.19
  • TSAT $7.21
  • 52 Week High
  • ZVRA $13.16
  • TSAT $29.91
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 50.02
  • TSAT 43.66
  • Support Level
  • ZVRA $10.69
  • TSAT $22.50
  • Resistance Level
  • ZVRA $11.37
  • TSAT $24.80
  • Average True Range (ATR)
  • ZVRA 0.49
  • TSAT 1.65
  • MACD
  • ZVRA -0.21
  • TSAT -0.67
  • Stochastic Oscillator
  • ZVRA 12.50
  • TSAT 10.73

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About TSAT Telesat Corporation and Class B Variable Voting Shares

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

Share on Social Networks: